FDA Warning Letter — Pharmaplast S.A.E.
The FDA took a Warning Letter action against Pharmaplast S.A.E. on April 13, 2023 (Alexandria, Egypt). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.
Action Details
- Facility
- Pharmaplast S.A.E.
- Date
- April 13, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Center
- CDER
- Location
- Alexandria (Egypt)